Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial ☆
Titel:
Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial ☆
Auteur:
van Wilpe, S. Kloots, I.S.H. Slootbeek, P.H.J. den Brok, M. Westdorp, H. Franken, M.D. Coskunturk, M. Osinga, T. Bloemendal, H. Adema, G. Smeenk, R.J. Nagarajah, J. van Ipenburg, J. Kroeze, L.I. Ligtenberg, M.J.L. Schalken, J. Gerritsen, W.R. Mehra, N.